Kaufmann M, Kubli F, Volm M, von Fournier D, Reus W
Strahlentherapie. 1978 Apr;154(4):277-81.
A technique of short-term tests in vitro by means of the incubation of tumor cell suspensions is utilized as a radioactive-biochemical method for pretherapeutic determination of the resistance in human cancers of the breast. Cell suspensions from primary tumors and metastases reveal individually different responses to cytostatics in vitro. It is possible, therewith, to differentiate two tumor collectives related to in vivo resistant or in vivo sensitive tumors. The responses of the primary lesion and the axillary lymphatic metastasis of the same carcinoma may in single cases also differ in vitro, according to clinical experience with the therapy of breast cancer. A distinct relation can be shown between the histological type of a carcinoma and its in vitro capacity of resistance.
一种通过肿瘤细胞悬液培养进行体外短期检测的技术,被用作一种放射性生化方法,用于治疗前测定人类乳腺癌的耐药性。来自原发性肿瘤和转移灶的细胞悬液在体外对细胞抑制剂显示出各自不同的反应。因此,有可能区分出与体内耐药或体内敏感肿瘤相关的两种肿瘤群体。根据乳腺癌治疗的临床经验,同一癌症的原发性病变和腋窝淋巴结转移灶在体外的反应在个别情况下也可能不同。可以显示出癌的组织学类型与其体外耐药能力之间存在明显的关系。